Save
National Strategy for Chronic Subdural Hematoma Treatment and Research in Denmark
Author(s): ,
T.S.R. Jensen
Affiliations:
Rigshospitalet, Department of Neurosurgery, Copenhagen Ø, Denmark
,
N. Andersen-Ranberg
Affiliations:
Rigshospitalet, Department of Neurosurgery, Copenhagen Ø, Denmark
,
F.R. Poulsen
Affiliations:
Odense University Hospital, Department of Neurosurgery, Odense, Denmark
,
B. Bergholt
Affiliations:
Aarhus University Hospital, Department of Neurosurgery, Aarhus, Denmark
,
T. Hundsholt
Affiliations:
Aalborg University Hospital, Department of Neurosurgery, Aalborg, Denmark
K. Fugleholm
Affiliations:
Rigshospitalet, Department of Neurosurgery, Copenhagen Ø, Denmark
EANS Academy. Jensen T. Oct 21, 2018; 225780; EP5002
Mr. Thorbj¿rn S¿ren Jensen
Mr. Thorbj¿rn S¿ren Jensen
Login now to access Regular content available to all registered users.

Access to Privileged content is currently a membership benefit.

Click here to join EANS or renew your membership.
Abstract
Discussion Forum (0)
Rate & Comment (0)
The purpose of a national strategy for treatment of a disease is to optimize patient care, while creating an optimal platform for quality control and research. A national strategy with standardization of treatment requires cooperation between multiple medical specialties and health professionals, while taking place over long distances, thus complicating the implementation and regulation of a standardized treatment. Chronic subdural hematoma (CSDH) is a collection of liquefied blood between the dura mater and arachnoid layer of the brain. The incidence of CSDH increases with age and with an ageing population, a rise in CSDH prevalence is anticipated. In Denmark neurosurgery is divided among four departments servicing a population of 5.75 million inhabitants. The Danish Chronic Subdural Hematoma Study (DACSUHS) was established in 2012 on behest of the four neurosurgical departments in order to improve treatment, research and development as well as creating national guidelines for CSDH management, approved by the Danish Neurosurgical Society. DACSUHS completed a three year national retrospective cohort study of all CSDH patients admitted to a neurosurgical department. On the basis of the results and a literature review, national guidelines for the treatment of CSDH have been published and implemented achieving a uniform treatment strategy for CSDH across neurosurgical departments in Denmark. This includes standardization of preoperative treatment instructions, surgical procedure and written patient information. Hence the management of a CSDH patient in Denmark is identical regardless of geographical region, hospital and surgeon.We will now use this unity in methodology as a research platform for randomized controlled studies.With this abstract we describe the process of standardization the preoperative, operative and postoperative treatment for CSDH in Denmark.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings